In addition, obesity and smoking significantly increase ACE2 expression in the lungs and bronchial epithelium [55, 56]; this could further explain the higher rates of obesity and smoking in Groups 3 and 4 with lower respiratory symptoms. Here, ACE2 is linked to obesity due to melanocortin 4 receptor deficiency.